3D Printing Will Cost The World USD100 Billion, Says Study 19/02/2014 by Julia Fraser for Intellectual Property Watch 1 Comment A recent report predicts the loss of at least $100 billion per year in intellectual property globally by 2018 as a result of 3D printing.
Battles Over Patents: Is India Changing The Rules Of The Game? 18/02/2014 by Ranjitha Balasubramanyam for Intellectual Property Watch 4 Comments Over the last couple of years, news of pharmaceutical patents and India’s attempts to protect and manage its market has caught the attention of intellectual property observers everywhere and the pharmaceutical industry in particular.
Biopharma Industries, Others Urge Caution In US Patent Reform 12/02/2014 by William New, Intellectual Property Watch Leave a Comment A coalition of large and small companies and organisation – including the leading trade associations for the US pharmaceutical and biotechnology industries – has asked the US Congress to use caution in rewriting patent laws so as not to cause unintended harm to their ability to innovate.
USTR Announces “Notorious” Markets For Counterfeiting, Piracy In 2013 12/02/2014 by William New, Intellectual Property Watch 2 Comments The Office of the United States Trade Representative today published its annual list of online and physical marketplaces worldwide that are most engaged in sales and trafficking of counterfeit and pirated goods.
Alert: Pharma IPR 2014 Conference In Mumbai, 26-28 February 10/02/2014 by Intellectual Property Watch Leave a Comment Dear Subscribers, CPhI’s 3rd Annual Pharma IPR 2014 conference to take place from 26-28 February, 2014 in Mumbai, India will have techno-legal experts from over 10+ regions speaking on the recent case studies on global Pharma and Biopharma patent laws. Among them, Jeffery Alan Hovden, Partner, Robins, Kaplan, Miller & Ciresi LLP from US will be speaking on critical developments in US pharma patent law in the year 2013 which have affected pharma and biopharma industry. He will also share best strategies on how Indian generic-drug and biologics enterprises need to go forward with their US-related projects. Some of the critical concerns he is planning to address include: Which pharmaceutical and diagnostic compounds and processes can even obtain a US patent? Whether the new, cheap and fast patent-challenge procedures are right for Indian companies in the life-sciences area? How to avoid paying the attorney fees for the other side in US litigation and indeed, how an Indian company might turn the tables and have the other side pay the company’s attorney fees? You can view his insights on “US Patent Law in 2013: Winds of Change” by clicking here. To optimise interactions with the audience, he and other global techno-legal experts would also be available in query handling sessions as well as one-on-one meetings, to discuss your concerns related to the US patent system. Click here to go through the detailed programme agenda. You can read more about the conference speakers here. To be a part of this exclusive event, please contact the organisers at +91 (22) 6172 7001 / conferences-india@ubm.com, or register online and take advantage of the special offers for you as you are our subscribers. P.S. You may find one of his earlier presentations on “From Small to Big: Some useful points in the coming shift from customary drugs to biologics” interesting – View the presentation here
Move On Data Protection Or Fail On TTIP, EU Parliament Chair Says 02/02/2014 by Monika Ermert for Intellectual Property Watch 2 Comments At the Munich Security Conference a year ago, there was a considerable first push for the Transatlantic Trade and Investment Partnership (TTIP). Eight months after the start of official TTIP negotiations and with the Snowden revelations in between, the tone at the 50th edition of the high-level foreign policy event in Munich is somewhat changed.
US Highest, India Lowest On US Chamber International IP Index 31/01/2014 by Julia Fraser for Intellectual Property Watch Leave a Comment The United States Chamber of Commerce Global Intellectual Property Center this week released a report ranking 25 countries on their IP environment.
In State Of The Union, Obama Highlights Need For Patent Reform, Trade 29/01/2014 by Intellectual Property Watch 1 Comment In the annual State of the Union speech of the United States president to Congress last night, President Obama described an innovation race, and highlighted the importance of trade agreements and passage of patent reform legislation.
Year Ahead: In US, 2014 Promises Bad News For Patent Trolls And Trademark Owners 15/01/2014 by Steven Seidenberg for Intellectual Property Watch Leave a Comment 2013 was an awkward year in the United States for so-called “patent trolls.” These companies, whose primary business is monetising their patents through licensing and litigation, faced growing criticism from academics, business executives, and US government officials. 2014 could prove even worse for trolls: America’s Congress, courts and executive branch are now considering various measures that would make patent trolling more difficult. And those are just some of the major changes that are likely to roil the US IP system this year.
Event: The 6th Annual Corporate IP Counsel Forum 13/01/2014 by Intellectual Property Watch Leave a Comment March 19-20, 2014 – Affinia Manhattan – New York City – www.worldcongress.com/corporateIP Optimize your IP portfolio. In this cross-industry event, the most timely and critical issues will be discussed and analyzed by senior counsel from Bank of America, General Mills, Honeywell, IBM, MLB Advanced Media, MasterCard, S.C. Johnson, and more; providing insight and strategies to help you tackle the latest challenges in IP. IP-Watch Reader Discount: when reserving your seat, use promo code IPW200 to take $200.00 off the current registration fee.